Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.02
HCA's Cash-to-Debt is ranked lower than
97% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
HCA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.14
Current: 0.02
0
0.14
Equity-to-Asset -0.19
HCA's Equity-to-Asset is ranked lower than
97% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. HCA: -0.19 )
Ranked among companies with meaningful Equity-to-Asset only.
HCA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.23 Max: 0.42
Current: -0.19
-0.5
0.42
Debt-to-Equity -4.86
HCA's Debt-to-Equity is ranked lower than
99.99% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. HCA: -4.86 )
Ranked among companies with meaningful Debt-to-Equity only.
HCA' s Debt-to-Equity Range Over the Past 10 Years
Min: -4.86  Med: 0.84 Max: 4.38
Current: -4.86
-4.86
4.38
Debt-to-EBITDA 3.95
HCA's Debt-to-EBITDA is ranked lower than
58% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. HCA: 3.95 )
Ranked among companies with meaningful Debt-to-EBITDA only.
HCA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.7  Med: 4.44 Max: 5.86
Current: 3.95
3.7
5.86
Interest Coverage 3.51
HCA's Interest Coverage is ranked lower than
71% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. HCA: 3.51 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.09  Med: 2.3 Max: 3.62
Current: 3.51
1.09
3.62
Piotroski F-Score: 6
Altman Z-Score: 2.11
Beneish M-Score: -2.80
WACC vs ROIC
3.90%
16.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 13.90
HCA's Operating Margin % is ranked higher than
75% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. HCA: 13.90 )
Ranked among companies with meaningful Operating Margin % only.
HCA' s Operating Margin % Range Over the Past 10 Years
Min: 7.48  Med: 13.99 Max: 15.86
Current: 13.9
7.48
15.86
Net Margin % 6.24
HCA's Net Margin % is ranked higher than
65% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. HCA: 6.24 )
Ranked among companies with meaningful Net Margin % only.
HCA' s Net Margin % Range Over the Past 10 Years
Min: 2.37  Med: 4.71 Max: 8.3
Current: 6.24
2.37
8.3
ROA % 7.78
HCA's ROA % is ranked higher than
79% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. HCA: 7.78 )
Ranked among companies with meaningful ROA % only.
HCA' s ROA % Range Over the Past 10 Years
Min: 2.79  Med: 5.66 Max: 9.71
Current: 7.78
2.79
9.71
ROC (Joel Greenblatt) % 31.84
HCA's ROC (Joel Greenblatt) % is ranked higher than
71% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. HCA: 31.84 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HCA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.15  Med: 30.35 Max: 37.66
Current: 31.84
23.15
37.66
3-Year Revenue Growth Rate 12.30
HCA's 3-Year Revenue Growth Rate is ranked higher than
66% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. HCA: 12.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HCA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.8  Med: 8.6 Max: 24.3
Current: 12.3
-7.8
24.3
3-Year EBITDA Growth Rate 14.80
HCA's 3-Year EBITDA Growth Rate is ranked higher than
70% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. HCA: 14.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HCA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10  Med: 8.45 Max: 39.4
Current: 14.8
-10
39.4
3-Year EPS without NRI Growth Rate 29.40
HCA's 3-Year EPS without NRI Growth Rate is ranked higher than
80% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. HCA: 29.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HCA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.7 Max: 88.4
Current: 29.4
0
88.4
GuruFocus has detected 2 Warning Signs with HCA Healthcare Inc HCA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCA's 30-Y Financials

Financials (Next Earnings Date: 2018-01-31)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

HCA Guru Trades in Q4 2016

Bill Nygren 2,200,000 sh (New)
John Hussman 50,000 sh (New)
Lee Ainslie 44,730 sh (New)
Paul Tudor Jones 7,000 sh (New)
First Pacific Advisors 16,500 sh (New)
Paul Singer 885,000 sh (New)
Jeremy Grantham 47,400 sh (+977.27%)
Glenn Greenberg 3,617,751 sh (+44.79%)
Larry Robbins 18,181,441 sh (+13.71%)
Vanguard Health Care Fund 12,087,883 sh (+3.47%)
Mario Gabelli 50,400 sh (unchged)
Larry Robbins 250,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 304,824 sh (unchged)
Steve Mandel Sold Out
Jim Simons Sold Out
David Tepper 1,145,250 sh (-7.41%)
David Dreman 19,562 sh (-19.38%)
John Paulson 111,600 sh (-31.32%)
Joel Greenblatt 116,944 sh (-69.18%)
» More
Q1 2017

HCA Guru Trades in Q1 2017

Leucadia National 5,676 sh (New)
Jim Simons 282,100 sh (New)
Joel Greenblatt 325,689 sh (+178.50%)
Jeremy Grantham 102,720 sh (+116.71%)
Bill Nygren 2,216,000 sh (+0.73%)
Larry Robbins 250,000 sh (unchged)
John Hussman 50,000 sh (unchged)
First Pacific Advisors 16,500 sh (unchged)
John Paulson Sold Out
Paul Singer Sold Out
Mario Gabelli 49,500 sh (-1.79%)
David Dreman 19,073 sh (-2.50%)
Vanguard Health Care Fund 11,321,278 sh (-6.34%)
Glenn Greenberg 3,097,983 sh (-14.37%)
Paul Tudor Jones 5,607 sh (-19.90%)
Larry Robbins 14,265,265 sh (-21.54%)
Lee Ainslie 32,270 sh (-27.86%)
David Tepper 487,711 sh (-57.41%)
Eaton Vance Worldwide Health Sciences Fund 224,376 sh (-26.39%)
» More
Q2 2017

HCA Guru Trades in Q2 2017

Charles Brandes 126,824 sh (New)
John Paulson 90,000 sh (New)
Jim Simons 642,700 sh (+127.83%)
John Hussman 75,800 sh (+51.60%)
Lee Ainslie 46,550 sh (+44.25%)
Jeremy Grantham 143,620 sh (+39.82%)
Larry Robbins 14,899,289 sh (+4.44%)
Joel Greenblatt 339,339 sh (+4.19%)
David Dreman 19,771 sh (+3.66%)
Mario Gabelli 49,500 sh (unchged)
First Pacific Advisors 16,500 sh (unchged)
Bill Nygren 2,216,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 224,376 sh (unchged)
Leucadia National Sold Out
Paul Tudor Jones Sold Out
Glenn Greenberg 3,080,347 sh (-0.57%)
Vanguard Health Care Fund 11,002,078 sh (-2.82%)
David Tepper 167,711 sh (-65.61%)
» More
Q3 2017

HCA Guru Trades in Q3 2017

Charles Brandes 686,968 sh (+441.67%)
Lee Ainslie 68,850 sh (+47.91%)
Bill Nygren 2,916,000 sh (+31.59%)
First Pacific Advisors 20,500 sh (+24.24%)
David Tepper 183,711 sh (+9.54%)
David Dreman 21,298 sh (+7.72%)
Larry Robbins 15,155,942 sh (+1.72%)
Vanguard Health Care Fund 11,002,078 sh (unchged)
John Hussman 75,800 sh (unchged)
Mario Gabelli 49,500 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 224,376 sh (unchged)
Jim Simons Sold Out
John Paulson Sold Out
Joel Greenblatt 327,576 sh (-3.47%)
Glenn Greenberg 2,918,273 sh (-5.26%)
Jeremy Grantham 3,400 sh (-97.63%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Glenn Greenberg 2017-09-30 Reduce -5.26%0.62%$76.25 - $87.24 $ 93.0115%2,918,273
Bill Nygren 2017-09-30 Add 31.59%0.31%$76.25 - $87.24 $ 93.0115%2,916,000
Charles Brandes 2017-09-30 Add 441.67%0.91%$76.25 - $87.24 $ 93.0115%686,968
Joel Greenblatt 2017-09-30 Reduce -3.47%0.01%$76.25 - $87.24 $ 93.0115%327,576
David Tepper 2017-09-30 Add 9.54%0.02%$76.25 - $87.24 $ 93.0115%183,711
David Dreman 2017-09-30 Add 7.72%0.07%$76.25 - $87.24 $ 93.0115%21,298
John Paulson 2017-09-30 Sold Out 0.11%$76.25 - $87.24 $ 93.0115%0
Vanguard Health Care Fund 2017-06-30 Reduce -2.82%0.06%$81.26 - $89.33 $ 93.0110%11,002,078
Glenn Greenberg 2017-06-30 Reduce -0.57%0.07%$81.26 - $89.33 $ 93.0110%3,080,347
Joel Greenblatt 2017-06-30 Add 4.19%0.02%$81.26 - $89.33 $ 93.0110%339,339
David Tepper 2017-06-30 Reduce -65.61%0.47%$81.26 - $89.33 $ 93.0110%167,711
Charles Brandes 2017-06-30 New Buy0.17%$81.26 - $89.33 $ 93.0110%126,824
John Paulson 2017-06-30 New Buy0.11%$81.26 - $89.33 $ 93.0110%90,000
David Dreman 2017-06-30 Add 3.66%0.03%$81.26 - $89.33 $ 93.0110%19,771
Leucadia National 2017-06-30 Sold Out 0.04%$81.26 - $89.33 $ 93.0110%0
Vanguard Health Care Fund 2017-03-31 Reduce -6.34%0.14%$74.46 - $90.49 $ 93.0112%11,321,278
Glenn Greenberg 2017-03-31 Reduce -14.37%1.83%$74.46 - $90.49 $ 93.0112%3,097,983
Bill Nygren 2017-03-31 Add 0.73%0.01%$74.46 - $90.49 $ 93.0112%2,216,000
David Tepper 2017-03-31 Reduce -57.41%0.86%$74.46 - $90.49 $ 93.0112%487,711
Joel Greenblatt 2017-03-31 Add 178.50%0.24%$74.46 - $90.49 $ 93.0112%325,689
Mario Gabelli 2017-03-31 Reduce -1.79%$74.46 - $90.49 $ 93.0112%49,500
David Dreman 2017-03-31 Reduce -2.50%0.02%$74.46 - $90.49 $ 93.0112%19,073
Leucadia National 2017-03-31 New Buy0.04%$74.46 - $90.49 $ 93.0112%5,676
John Paulson 2017-03-31 Sold Out 0.11%$74.46 - $90.49 $ 93.0112%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:XTER:FME, XTER:FRE, NYSE:DVA, XKLS:5225, ASX:RHC, NYSE:UHS, BKK:BDMS, LSE:NMC, ASX:SHL, SZSE:300015, LSE:MDC, HAM:CLS1, NYSE:MD, NYSE:HLS, NYSE:EVHC, BKK:BH, NYSE:CHE, NAS:ACHC, ASX:HSO, JSE:LHC » details
Traded in other countries:2BH.Germany,
Headquarter Location:USA
HCA Healthcare Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals, and rehabilitation hospitals. The company also operates freestanding surgery centers.

Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the United States. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services. HCA has operations in 20 states and in England, but a majority of its operations are in the Southern United States, particularly in Florida and Texas. Outpatient services make up about 40% of HCA's patient revenue.

Guru Investment Theses on HCA Healthcare Inc

Bill Nygren Comments on HCA - Jan 10, 2017

HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value.

From Bill Nygren (Trades, Portfolio)'s Oakmark Fund fourth quarter 2016 commentary.

Check out Bill Nygren latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 13.27
HCA's PE Ratio is ranked higher than
90% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. HCA: 13.27 )
Ranked among companies with meaningful PE Ratio only.
HCA' s PE Ratio Range Over the Past 10 Years
Min: 4.08  Med: 12.95 Max: 19.67
Current: 13.27
4.08
19.67
Forward PE Ratio 12.24
HCA's Forward PE Ratio is ranked higher than
95% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. HCA: 12.24 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 13.27
HCA's PE Ratio without NRI is ranked higher than
91% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. HCA: 13.27 )
Ranked among companies with meaningful PE Ratio without NRI only.
HCA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.08  Med: 12.95 Max: 19.67
Current: 13.27
4.08
19.67
Price-to-Owner-Earnings 13.79
HCA's Price-to-Owner-Earnings is ranked higher than
85% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. HCA: 13.79 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.27  Med: 12.21 Max: 58.95
Current: 13.79
6.27
58.95
PS Ratio 0.82
HCA's PS Ratio is ranked higher than
79% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. HCA: 0.82 )
Ranked among companies with meaningful PS Ratio only.
HCA' s PS Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.7 Max: 1.06
Current: 0.82
0.32
1.06
Price-to-Free-Cash-Flow 14.21
HCA's Price-to-Free-Cash-Flow is ranked higher than
81% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. HCA: 14.21 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.08  Med: 11.68 Max: 17.18
Current: 14.21
4.08
17.18
Price-to-Operating-Cash-Flow 6.53
HCA's Price-to-Operating-Cash-Flow is ranked higher than
88% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. HCA: 6.53 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.57  Med: 5.71 Max: 8.48
Current: 6.53
2.57
8.48
EV-to-EBIT 10.69
HCA's EV-to-EBIT is ranked higher than
91% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. HCA: 10.69 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.5 Max: 12.6
Current: 10.69
6.3
12.6
EV-to-EBITDA 8.02
HCA's EV-to-EBITDA is ranked higher than
89% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. HCA: 8.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.8 Max: 9.4
Current: 8.02
5
9.4
EV-to-Revenue 1.57
HCA's EV-to-Revenue is ranked higher than
67% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. HCA: 1.57 )
Ranked among companies with meaningful EV-to-Revenue only.
HCA' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2  Med: 1.5 Max: 1.8
Current: 1.57
1.2
1.8
PEG Ratio 1.56
HCA's PEG Ratio is ranked higher than
79% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. HCA: 1.56 )
Ranked among companies with meaningful PEG Ratio only.
HCA' s PEG Ratio Range Over the Past 10 Years
Min: 0.65  Med: 2.18 Max: 6.07
Current: 1.56
0.65
6.07
Shiller PE Ratio 18.48
HCA's Shiller PE Ratio is ranked higher than
85% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. HCA: 18.48 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.14  Med: 15.23 Max: 23.02
Current: 18.48
6.14
23.02
Current Ratio 1.68
HCA's Current Ratio is ranked higher than
60% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. HCA: 1.68 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.52 Max: 2.25
Current: 1.68
0.81
2.25
Quick Ratio 1.41
HCA's Quick Ratio is ranked higher than
52% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. HCA: 1.41 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.35 Max: 2.12
Current: 1.41
0.71
2.12
Days Inventory 77.34
HCA's Days Inventory is ranked lower than
88% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 16.86 vs. HCA: 77.34 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 57.16  Med: 68.53 Max: 77.44
Current: 77.34
57.16
77.44
Days Sales Outstanding 51.13
HCA's Days Sales Outstanding is ranked lower than
61% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. HCA: 51.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.29 Max: 56.3
Current: 51.13
44.84
56.3
Days Payable 117.78
HCA's Days Payable is ranked higher than
73% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. HCA: 117.78 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 108.24  Med: 112.98 Max: 122.04
Current: 117.78
108.24
122.04

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 0.30
HCA's 5-Year Yield-on-Cost % is ranked lower than
98% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. HCA: 0.30 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HCA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 5.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HCA: 5.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -202.3  Med: 0.95 Max: 12
Current: 5.5
-202.3
12

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.58
HCA's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
74% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. HCA: 1.58 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.26  Med: 3.29 Max: 17.96
Current: 1.58
1.26
17.96
Price-to-Median-PS-Value 1.18
HCA's Price-to-Median-PS-Value is ranked higher than
52% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. HCA: 1.18 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.51  Med: 1 Max: 1.48
Current: 1.18
0.51
1.48
Price-to-Peter-Lynch-Fair-Value 1.27
HCA's Price-to-Peter-Lynch-Fair-Value is ranked higher than
73% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. HCA: 1.27 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HCA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.74  Med: 1.84 Max: 3.67
Current: 1.27
0.74
3.67
Earnings Yield (Greenblatt) % 9.35
HCA's Earnings Yield (Greenblatt) % is ranked higher than
93% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. HCA: 9.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 8  Med: 9.5 Max: 16
Current: 9.35
8
16
Forward Rate of Return (Yacktman) % 16.12
HCA's Forward Rate of Return (Yacktman) % is ranked higher than
71% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. HCA: 16.12 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.1  Med: 13.4 Max: 18.4
Current: 16.12
9.1
18.4

More Statistics

Revenue (TTM) (Mil) $42,693.00
EPS (TTM) $ 7.01
Beta0.22
Short Percentage of Float2.82%
52-Week Range $71.18 - 93.32
Shares Outstanding (Mil)354.05

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 43,358 45,744 47,532
EPS ($) 6.61 7.88 8.50
EPS without NRI ($) 6.61 7.88 8.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
11.63%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}